Literature DB >> 33158974

T cell factor 1: A master regulator of the T cell response in disease.

Giulia Escobar1, Davide Mangani1, Ana C Anderson2.   

Abstract

Recent advances have redefined a role for T cell factor 1 (TCF1) that goes beyond T cell development and T memory formation and encompasses new functions in the regulation of T cell biology. Here, we discuss the multifaceted and context-dependent role of TCF1 in peripheral T cells, particularly during disease-induced inflammatory states such as autoimmunity, cancer, and chronic infections. Understanding how TCF1 fine-tunes peripheral T cell biology holds the potential to tailor improved immune-targeted therapies.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2020        PMID： 33158974      PMCID： PMC8221367          DOI： 10.1126/sciimmunol.abb9726

Source DB:  PubMed          Journal:  Sci Immunol        ISSN： 2470-9468


  121 in total

1.  Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity.

Authors:  Miranda L Broz; Mikhail Binnewies; Bijan Boldajipour; Amanda E Nelson; Joshua L Pollack; David J Erle; Andrea Barczak; Michael D Rosenblum; Adil Daud; Diane L Barber; Sebastian Amigorena; Laura J Van't Veer; Anne I Sperling; Denise M Wolf; Matthew F Krummel
Journal:  Cancer Cell       Date:  2014-10-16       Impact factor: 31.743

Review 2.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

3.  CD8+ T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity.

Authors:  Laura M Snell; Bethany L MacLeod; Jaclyn C Law; Ivan Osokine; Heidi J Elsaesser; Kebria Hezaveh; Russell J Dickson; Marc A Gavin; Cynthia J Guidos; Tracy L McGaha; David G Brooks
Journal:  Immunity       Date:  2018-10-09       Impact factor: 31.745

4.  Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.

Authors:  Luca Gattinoni; Christopher A Klebanoff; Douglas C Palmer; Claudia Wrzesinski; Keith Kerstann; Zhiya Yu; Steven E Finkelstein; Marc R Theoret; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

5.  Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade.

Authors:  Kristen E Pauken; Morgan A Sammons; Pamela M Odorizzi; Sasikanth Manne; Jernej Godec; Omar Khan; Adam M Drake; Zeyu Chen; Debattama R Sen; Makoto Kurachi; R Anthony Barnitz; Caroline Bartman; Bertram Bengsch; Alexander C Huang; Jason M Schenkel; Golnaz Vahedi; W Nicholas Haining; Shelley L Berger; E John Wherry
Journal:  Science       Date:  2016-10-27       Impact factor: 47.728

6.  Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates.

Authors:  Yannick Simoni; Etienne Becht; Michael Fehlings; Chiew Yee Loh; Si-Lin Koo; Karen Wei Weng Teng; Joe Poh Sheng Yeong; Rahul Nahar; Tong Zhang; Hassen Kared; Kaibo Duan; Nicholas Ang; Michael Poidinger; Yin Yeng Lee; Anis Larbi; Alexis J Khng; Emile Tan; Cherylin Fu; Ronnie Mathew; Melissa Teo; Wan Teck Lim; Chee Keong Toh; Boon-Hean Ong; Tina Koh; Axel M Hillmer; Angela Takano; Tony Kiat Hon Lim; Eng Huat Tan; Weiwei Zhai; Daniel S W Tan; Iain Beehuat Tan; Evan W Newell
Journal:  Nature       Date:  2018-05-16       Impact factor: 49.962

7.  The lineage-defining factors T-bet and Bcl-6 collaborate to regulate Th1 gene expression patterns.

Authors:  Kenneth J Oestreich; Albert C Huang; Amy S Weinmann
Journal:  J Exp Med       Date:  2011-04-25       Impact factor: 14.307

8.  High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors.

Authors:  Jolanda Brummelman; Emilia M C Mazza; Giorgia Alvisi; Federico S Colombo; Andrea Grilli; Joanna Mikulak; Domenico Mavilio; Marco Alloisio; Francesco Ferrari; Egesta Lopci; Pierluigi Novellis; Giulia Veronesi; Enrico Lugli
Journal:  J Exp Med       Date:  2018-08-28       Impact factor: 14.307

9.  TOX is a critical regulator of tumour-specific T cell differentiation.

Authors:  Andrew C Scott; Friederike Dündar; Paul Zumbo; Smita S Chandran; Christopher A Klebanoff; Mojdeh Shakiba; Prerak Trivedi; Laura Menocal; Heather Appleby; Steven Camara; Dmitriy Zamarin; Tyler Walther; Alexandra Snyder; Matthew R Femia; Elizabeth A Comen; Hannah Y Wen; Matthew D Hellmann; Niroshana Anandasabapathy; Yong Liu; Nasser K Altorki; Peter Lauer; Olivier Levy; Michael S Glickman; Jonathan Kaye; Doron Betel; Mary Philip; Andrea Schietinger
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

10.  Chromatin states define tumour-specific T cell dysfunction and reprogramming.

Authors:  Mary Philip; Lauren Fairchild; Liping Sun; Ellen L Horste; Steven Camara; Mojdeh Shakiba; Andrew C Scott; Agnes Viale; Peter Lauer; Taha Merghoub; Matthew D Hellmann; Jedd D Wolchok; Christina S Leslie; Andrea Schietinger
Journal:  Nature       Date:  2017-05-17       Impact factor: 49.962
View more
  19 in total

1.  Downregulation of TCF1 in HIV Infection Impairs T-cell Proliferative Capacity by Disrupting Mitochondrial Function.

Authors:  Hong-Jiao Cai; Jue Shi; Lin-Bo Yin; Jie-Fu Zheng; Ya-Jing Fu; Yong-Jun Jiang; Hong Shang; Zi-Ning Zhang
Journal:  Front Microbiol       Date:  2022-07-06       Impact factor: 6.064

2.  Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products.

Authors:  Daniela Nascimento Silva; Michael Chrobok; Giulia Rovesti; Katie Healy; Arnika Kathleen Wagner; Panagiota Maravelia; Francesca Gatto; Massimiliano Mazza; Lucia Mazzotti; Volker Lohmann; Margaret Sällberg Chen; Matti Sällberg; Marcus Buggert; Anna Pasetto
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

3.  An autoimmune stem-like CD8 T cell population drives type 1 diabetes.

Authors:  Sofia V Gearty; Friederike Dündar; Paul Zumbo; Gabriel Espinosa-Carrasco; Mojdeh Shakiba; Francisco J Sanchez-Rivera; Nicholas D Socci; Prerak Trivedi; Scott W Lowe; Peter Lauer; Neeman Mohibullah; Agnes Viale; Teresa P DiLorenzo; Doron Betel; Andrea Schietinger
Journal:  Nature       Date:  2021-11-30       Impact factor: 69.504

Review 4.  Spatial determinants of CD8+ T cell differentiation in cancer.

Authors:  Katherine A Tooley; Giulia Escobar; Ana C Anderson
Journal:  Trends Cancer       Date:  2022-05-05

5.  Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues.

Authors:  Christin Friedrich; Renske L R E Taggenbrock; Rémi Doucet-Ladevèze; Gosia Golda; Rebekka Moenius; Panagiota Arampatzi; Natasja A M Kragten; Katharina Kreymborg; Mercedes Gomez de Agüero; Wolfgang Kastenmüller; Antoine-Emmanuel Saliba; Dominic Grün; Klaas P J M van Gisbergen; Georg Gasteiger
Journal:  Nat Immunol       Date:  2021-08-30       Impact factor: 25.606

6.  Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity.

Authors:  Alexandra Schnell; Linglin Huang; Meromit Singer; Anvita Singaraju; Rocky M Barilla; Brianna M L Regan; Alina Bollhagen; Pratiksha I Thakore; Danielle Dionne; Toni M Delorey; Mathias Pawlak; Gerd Meyer Zu Horste; Orit Rozenblatt-Rosen; Rafael A Irizarry; Aviv Regev; Vijay K Kuchroo
Journal:  Cell       Date:  2021-12-06       Impact factor: 41.582

Review 7.  The Potential of T Cell Factor 1 in Sustaining CD8+ T Lymphocyte-Directed Anti-Tumor Immunity.

Authors:  Sungmin Jung; Jea-Hyun Baek
Journal:  Cancers (Basel)       Date:  2021-01-29       Impact factor: 6.639

8.  Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy.

Authors:  Riyao Yang; Linlin Sun; Ching-Fei Li; Yu-Han Wang; Jun Yao; Hui Li; Meisi Yan; Wei-Chao Chang; Jung-Mao Hsu; Jong-Ho Cha; Jennifer L Hsu; Cheng-Wei Chou; Xian Sun; Yalan Deng; Chao-Kai Chou; Dihua Yu; Mien-Chie Hung
Journal:  Nat Commun       Date:  2021-02-05       Impact factor: 14.919

Review 9.  CD8+ T cell differentiation and dysfunction in cancer.

Authors:  Mary Philip; Andrea Schietinger
Journal:  Nat Rev Immunol       Date:  2021-07-12       Impact factor: 108.555

Review 10.  miR-181a-regulated pathways in T-cell differentiation and aging.

Authors:  Chulwoo Kim; Zhongde Ye; Cornelia M Weyand; Jörg J Goronzy
Journal:  Immun Ageing       Date:  2021-06-15       Impact factor: 6.400
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.